As resveratrol degraded DDX5 protein and the depletion of DDX5 inhibited the mTORC1 pathway and growth of prostate cancer cells, we evaluated the significance of degrading DDX5 in the anticancer effects of resveratrol. This evidence concerns the gene DDX5 and Familial prostate cancer.